Skip to content

Evaluation of A-DIVA Score Effectiveness at Admission for Preserving Venous Capital in Patients With Difficult Access

Randomized Controlled Clinical Trial Assessing the Effectiveness of a Venipuncture Strategy Adapted According to A-DIVA Score Results Compared to Standard Care in Reducing the Number of Punctures

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06952829
Acronym
ERV-ADIVA
Enrollment
600
Registered
2025-05-01
Start date
2025-04-21
Completion date
2028-09-30
Last updated
2025-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Internal Medicine, Neurology, Surgery

Keywords

Adult-Difficult IntraVenous Access (A-DIVA), capital venous preservation

Brief summary

In certain cases (e.g.: patient who are difficult to perfuse, thin veins, etc.), an increase in venipunctures performed by study nurses in healthcare services can lead to a loss of venous capital, repeated pain during punctures, discontinuous treatment follow-up and numerous requests for assistance from colleagues, including nurse anesthetists, but often too late. The main objective of project is to reduce the number of punctures to access the venous system after evaluation of adult patients upon entering the hospitalization department using the A-DIVA tool. the A-DIVA score predicts the difficulty in infusing an adult patient

Detailed description

This research evaluates the importance of assessing the venous capital access of hospitalized patients prior to the placement of an intravenous infusion, in order to save time in initiating therapeutic treatment and to prevent or reduce the number of venipunctures and the associated inconveniences (pain, discontinuous treatment monitoring). This approach aims to preserve the patient's venous capital. In the proposed study, investigators will evaluate the patients' venous capital using the Adult-Difficult IntraVenous Access (A-DIVA) tool upon hospital admission and during hospitalization before any peripheral intravenous (IV) catheter placement. During the inclusion visit, after obtaining informed consent, patients will be randomized into one of two groups: * Group A: Patients will undergo an evaluation of their venous capital by a study nurse using the Adult-Difficult IntraVenous Access (A-DIVA) tool prior to any peripheral IV catheter placement during hospitalization. * Group B: Patients will not undergo an evaluation of their venous capital using the Adult-Difficult IntraVenous Access (A-DIVA) tool prior to peripheral IV catheter placement. They will receive standard care as routinely provided in the hospital ward.

Interventions

OTHERevaluation of intravenous access of patients with Adult-Difficult IntraVenous Access (A-DIVA) score prior to puncturing subject

The patient's intravenous access will be evaluated using the A-DIVA score by the study nurse at the time of admission, prior to venipuncture performed by the care nurse

OTHERevaluation of intravenous access of patients with modified Adult-Difficult IntraVenous access(A-DIVA modified) score prior to puncturing subject

The patient's intravenous access will be evaluated using the A-DIVA-m score by the study nurse at the time of admission, prior to venipuncture performed by the care nurse

Sponsors

Centre Hospitalier Intercommunal Robert Ballanger
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

controlled, randomized study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and Female Adult Patients Aged 18 Years and Older * written informed consent given by patient * Affiliation to a social security system or equivalence system

Exclusion criteria

* Patients in Intensive Care Units * Patients with Psychiatric Disorders or Under Psychiatric Care * Minor Patients Under 18 Years of Age * Pregnant or Breastfeeding Women * Vulnerable and Protected Individuals as Defined by the Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2) * Patients Participating in Another Interventional Study * Dying patients * Patients Receiving Infusions of: * Chemotherapy Drugs with a pH \<5 or \>8 * Solutions with an Osmolarity \>900 mOsm/L * Patients refusing to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Number of Venipunctures Performed to Establish the First Peripheral Intravenous Line in the Hospital servicesPeriprocedural Venipuncture performed by study nurse from Day 0 (date of admission to hospital service) to Day 10 or until hospital discharge subjectNumber of Venipunctures Performed to Establish the First Peripheral Intravenous Line in the Hospital services

Secondary

MeasureTime frameDescription
pain score (numeric rating scale) during venipunctureDuring venipuncture from Day 0 to Day 10 or throughout the entire hospitalization periodassess the patient's pain on a scale of 0 to 10 at the time of the puncture. A lower score indicates less painful, a higher score means that patient is more painful.
duration of successful catheter placementDuring catheter placement from Day 0 to Day 10 or throughout the entire hospitalization periodduration of successful catheter placement

Countries

France

Contacts

Primary ContactEric MORTUREUX, PI
eric.mortureux@ght-gpne.fr01 49 36 70 41

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026